115 related articles for article (PubMed ID: 12850278)
21. Characterization of a carboxyterminal peptide fragment of the human choriogonadotropin beta-subunit excreted in the urine of a woman with choriocarcinoma.
Amr S; Wehmann RE; Birken S; Canfield RE; Nisula BC
J Clin Invest; 1983 Feb; 71(2):329-39. PubMed ID: 6185541
[TBL] [Abstract][Full Text] [Related]
22. Identification of cross-reactive and restricted epitopes localized on human chorionic gonadotropin beta-subunit by monoclonal antibodies.
Saboor-Yaraghi AA; Ghods R; Gharagozlou S; Roohi A; Khoshnoodi J; Towfighi F; Jeddi-Tehrani M; Shokri F
Hybrid Hybridomics; 2004 Apr; 23(2):101-7. PubMed ID: 15165483
[TBL] [Abstract][Full Text] [Related]
23. Development and characterization of a new, highly specific antibody to the human chorionic gonadotropin-beta fragment.
Krichevsky A; Birken S; O'Connor J; Bikel K; Schlatterer J; Yi C; Agosto G; Canfield R
Endocrinology; 1991 Mar; 128(3):1255-64. PubMed ID: 1705504
[TBL] [Abstract][Full Text] [Related]
24. [Choriogonadotropin measurements--critical assessment of new diagnostic possibilities].
Skałba P; Gajewska K; Bednarska-Czerwińska A
Ginekol Pol; 2004 Mar; 75(3):221-7. PubMed ID: 15181881
[TBL] [Abstract][Full Text] [Related]
25. Relative location of epitopes involved in synergistic antibody binding using human chorionic gonadotropin as a model.
Klonisch T; Delves PJ; Berger P; Panayotou G; Lapthorn AJ; Isaacs NW; Wick G; Lund T; Roitt IM
Eur J Immunol; 1996 Aug; 26(8):1897-905. PubMed ID: 8765037
[TBL] [Abstract][Full Text] [Related]
26. Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCG beta fragment from standard reference preparations and raw urine samples.
Birken S; Chen Y; Gawinowicz MA; Lustbader JW; Pollak S; Agosto G; Buck R; O'Connor J
Endocrinology; 1993 Sep; 133(3):1390-7. PubMed ID: 7689955
[TBL] [Abstract][Full Text] [Related]
27. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases.
Cole LA; Shahabi S; Butler SA; Mitchell H; Newlands ES; Behrman HR; Verrill HL
Clin Chem; 2001 Feb; 47(2):308-15. PubMed ID: 11159780
[TBL] [Abstract][Full Text] [Related]
28. [Monoclonal antibodies directed against the beta hCG subunit and against a synthetic peptide analog of the carboxyl-terminal end. Clinical use in vivo and in vitro].
Bellet D; Ozturk M; Bidart JM; Strugo MC; Troalen F; Caillaud JM; Lumbroso J; Jolivet M; Tartar A; Amiel JL
Ann Endocrinol (Paris); 1984; 45(4-5):335-41. PubMed ID: 6085542
[TBL] [Abstract][Full Text] [Related]
29. Epitope-selective, monoclonal-antibody-based immunoradiometric assays of predictable specificity for differential measurement of choriogonadotropin and its subunits.
Schwarz S; Berger P; Wick G
Clin Chem; 1985 Aug; 31(8):1322-8. PubMed ID: 2410164
[TBL] [Abstract][Full Text] [Related]
30. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG.
Cole LA; Dai D; Butler SA; Leslie KK; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):145-50. PubMed ID: 16631920
[TBL] [Abstract][Full Text] [Related]
31. Choriocarcinoma-like human chorionic gonadotrophin (HCG) and HCG bioactivity during the first trimester of pregnancy.
Mock P; Kovalevskaya G; O'Connor JF; Campana A
Hum Reprod; 2000 Oct; 15(10):2209-14. PubMed ID: 11006201
[TBL] [Abstract][Full Text] [Related]
32. The ISOBM TD-7 Workshop on hCG and related molecules. Towards user-oriented standardization of pregnancy and tumor diagnosis: assignment of epitopes to the three-dimensional structure of diagnostically and commercially relevant monoclonal antibodies directed against human chorionic gonadotropin and derivatives.
Berger P; Sturgeon C; Bidart JM; Paus E; Gerth R; Niang M; Bristow A; Birken S; Stenman UH
Tumour Biol; 2002; 23(1):1-38. PubMed ID: 11893904
[TBL] [Abstract][Full Text] [Related]
33. Tumor- and pregnancy-derived isoforms of human chorionic gonadotropin: biological and diagnostic relevance.
Lottersberger C; Hoermann R; Mann K; Schwarz S; Berger P
Horm Res; 2003; 59(3):125-34. PubMed ID: 12637792
[TBL] [Abstract][Full Text] [Related]
34. Determination of human chorionic gonadotropin.
Stenman UH; Alfthan H
Best Pract Res Clin Endocrinol Metab; 2013 Dec; 27(6):783-93. PubMed ID: 24275190
[TBL] [Abstract][Full Text] [Related]
35. Hyperglycosylated hCG, a review.
Cole LA
Placenta; 2010 Aug; 31(8):653-64. PubMed ID: 20619452
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of nicked human chorionic gonadotropin content in clinical specimens by a specific immunometric assay.
Kovalevskaya G; Birken S; Kakuma T; Schlatterer J; O'Connor JF
Clin Chem; 1999 Jan; 45(1):68-77. PubMed ID: 9895340
[TBL] [Abstract][Full Text] [Related]
37. Development, characterization, and application of monoclonal antibodies to the native and synthetic beta COOH-terminal portion of human chorionic gonadotropin (hCG) that distinguish between the native and desialylated forms of hCG.
Krichevsky A; Birken S; O'Connor J; Acevedo HF; Bikel K; Lustbader J; Hartree A; Canfield RE
Endocrinology; 1994 Mar; 134(3):1139-45. PubMed ID: 7509735
[TBL] [Abstract][Full Text] [Related]
38. Polyclonal antibodies against the polypeptide and carbohydrate epitopes of recombinant human choriogonadotropin beta-subunit.
Chen W; Bahl OP
Mol Cell Endocrinol; 1992 Jul; 86(1-2):57-66. PubMed ID: 1380928
[TBL] [Abstract][Full Text] [Related]
39. Highly sensitive radioimmunoassay for chorionic gonadotropin in human urine.
Ayala AR; Nisula BC; Chen HC; Hodgen GD; Ross GT
J Clin Endocrinol Metab; 1978 Oct; 47(4):767-73. PubMed ID: 95624
[TBL] [Abstract][Full Text] [Related]
40. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
